Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | NB004 |
| Synonyms | |
| Therapy Description |
NB004 is a pan-PIM kinase inhibitor, which potentially decreases tumor cell proliferation, and inhibits tumor growth (Cancer Res (2024) 84 (7_Supplement): CT116). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| NB004 | NB 004|NB-004|GDC 0570|GDC0570|GDC-0570 | PIM Inhibitor (Pan) 10 | NB004 is a pan-PIM kinase inhibitor, which potentially decreases tumor cell proliferation, and inhibits tumor growth (Cancer Res (2024) 84 (7_Supplement): CT116). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05036291 | Phase I | NB004 | A Study of NB004 in Patients With Advanced Solid Tumors | Recruiting | USA | 1 |